U.S. FDA Issues Complete Response Letter for Baricitinib
Go back to U.S. FDA Issues Complete Response Letter for Baricitinib| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 123.89 -0.55 (0.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.44 | 52 Week High | $118.49 | |||
| Open | $125.72 | 52 Week Low | $55.00 | |||
| Day High | $126.00 | P/E | N/A | |||
| Day Low | $123.07 | EPS | $-0.56 | |||
| Volume | 1,210,010 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1183.46 +1.57 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1181.89 | 52 Week High | $88.16 | |||
| Open | $1185.32 | 52 Week Low | $67.88 | |||
| Day High | $1190.00 | P/E | 273.95 | |||
| Day Low | $1160.84 | EPS | $4.32 | |||
| Volume | 1,924,379 | |||||
